円
1382.00
Jun 7
Business Description
Shin Nippon Biomedical Laboratories Ltd
ISIN : JP3379950003
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.77 | |||||
Debt-to-EBITDA | 3.68 | |||||
Interest Coverage | 29.99 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.04 | |||||
Beneish M-Score | -2.15 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.5 | |||||
3-Year EBITDA Growth Rate | 17.4 | |||||
3-Year EPS without NRI Growth Rate | 20.3 | |||||
3-Year Book Growth Rate | 29.4 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.55 | |||||
9-Day RSI | 51.11 | |||||
14-Day RSI | 48.59 | |||||
6-1 Month Momentum % | -10.93 | |||||
12-1 Month Momentum % | -33.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.31 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 299.77 | |||||
Days Sales Outstanding | 70.38 | |||||
Days Payable | 14.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.62 | |||||
Dividend Payout Ratio | 0.37 | |||||
3-Year Dividend Growth Rate | 115.4 | |||||
Forward Dividend Yield % | 3.62 | |||||
5-Year Yield-on-Cost % | 94.25 | |||||
Shareholder Yield % | -10.68 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54 | |||||
Operating Margin % | 15.74 | |||||
Net Margin % | 20.91 | |||||
FCF Margin % | -24.57 | |||||
ROE % | 18.59 | |||||
ROA % | 8.23 | |||||
ROIC % | 5.65 | |||||
ROC (Joel Greenblatt) % | 28.49 | |||||
ROCE % | 15.67 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.4 | |||||
PE Ratio without NRI | 10.32 | |||||
Shiller PE Ratio | 24.28 | |||||
PEG Ratio | 0.42 | |||||
PS Ratio | 2.18 | |||||
PB Ratio | 1.69 | |||||
Price-to-Tangible-Book | 1.8 | |||||
Price-to-Operating-Cash-Flow | 27.31 | |||||
EV-to-EBIT | 10.28 | |||||
EV-to-EBITDA | 10.28 | |||||
EV-to-Revenue | 2.76 | |||||
EV-to-FCF | -11.25 | |||||
Price-to-Projected-FCF | 1.57 | |||||
Price-to-Median-PS-Value | 1.15 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.41 | |||||
Price-to-Graham-Number | 0.91 | |||||
Earnings Yield (Greenblatt) % | 9.73 | |||||
FCF Yield % | -11.29 | |||||
Forward Rate of Return (Yacktman) % | 21.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shin Nippon Biomedical Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 26,450.468 | ||
EPS (TTM) (円) | 132.854 | ||
Beta | -0.45 | ||
Volatility % | 24.43 | ||
14-Day RSI | 48.59 | ||
14-Day ATR (円) | 48.2798 | ||
20-Day SMA (円) | 1372.95 | ||
12-1 Month Momentum % | -33.55 | ||
52-Week Range (円) | 1286 - 2465 | ||
Shares Outstanding (Mil) | 41.63 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shin Nippon Biomedical Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shin Nippon Biomedical Laboratories Ltd Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Shin Nippon Biomedical Laboratories Ltd Frequently Asked Questions
What is Shin Nippon Biomedical Laboratories Ltd(TSE:2395)'s stock price today?
When is next earnings date of Shin Nippon Biomedical Laboratories Ltd(TSE:2395)?
Does Shin Nippon Biomedical Laboratories Ltd(TSE:2395) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |